
It’s been a busy week on Pharmafile.com over the last seven days. Europe’s first biosimilar treatment for cancer continues to …

It’s Friday again, and this week in pharma has seen a slew of positive clinical trial results released in Crohn’s …

Stories have erupted out of the industry this week with leaps forward in malaria and cancer R&D, some controversial drug …

Two of our top five stories this month are about one company in particular – a company that’s having a …

Moving into February,and the first weeks of Trump’s term, the US President has dominated the headlines in the industry as …

We’re nearing the end of the first month of the year and acqusitions have begun to introduce themselves with bang, …

It’s Friday, and there have been some big revelations for the pharma industry this week. Brexit, the ever-present hot topic …

We’re now into 2017 in earnest and news of acquisitions, partnerships, R&D advancements and scandals are back in force. Cancer …

Happy New Year from us here at Pharmafocus! As we leave 2016 behind, take a look at ten of its …

The start of 2017 has already had some big stories hit the news, with many companies taking the opportunity to …

As we’re now in the New Year, here at Pharmafocus, we thought we would do a recap of the ten …

Christmas is nearly here, but there isn’t much Christmas cheer to be had in the pharmaceutical industry. It’s been a …

Christmas is drawing ever closer, but that doesn’t mean the industry is slowing down. This week, features from the latest …

This week has been an interesting one for pharmaceutical innovation. A number of stories and studies have arisen about trialling …

This week has seen the pharmaceutical industry return to business as usual after the presidential election provided a boost to …